These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26420874)

  • 1. CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection.
    Harper SJ; Ali JM; Wlodek E; Negus MC; Harper IG; Chhabra M; Qureshi MS; Mallik M; Bolton E; Bradley JA; Pettigrew GJ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12788-93. PubMed ID: 26420874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copresentation of intact and processed MHC alloantigen by recipient dendritic cells enables delivery of linked help to alloreactive CD8 T cells by indirect-pathway CD4 T cells.
    Sivaganesh S; Harper SJ; Conlon TM; Callaghan CJ; Saeb-Parsy K; Negus MC; Motallebzadeh R; Bolton EM; Bradley JA; Pettigrew GJ
    J Immunol; 2013 Jun; 190(11):5829-38. PubMed ID: 23630361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell Allorecognition Pathways in Solid Organ Transplantation.
    Siu JHY; Surendrakumar V; Richards JA; Pettigrew GJ
    Front Immunol; 2018; 9():2548. PubMed ID: 30455697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
    Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3039. PubMed ID: 30740108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Acquisition of MHC:Peptide Complexes by Recipient Cells Contributes to the Generation of Anti-Graft CD8
    Smyth LA; Lechler RI; Lombardi G
    Am J Transplant; 2017 Jan; 17(1):60-68. PubMed ID: 27495898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the contribution of CD4+ T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression.
    Simeonovic CJ; Brown DJ; Townsend MJ; Wilson JD
    Cell Transplant; 1996; 5(5):525-41. PubMed ID: 8889212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.
    Smyth LA; Ratnasothy K; Moreau A; Alcock S; Sagoo P; Meader L; Tanriver Y; Buckland M; Lechler R; Lombardi G
    J Immunol; 2013 May; 190(9):4848-60. PubMed ID: 23536635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
    Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
    Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.
    Boisgérault F; Liu Y; Anosova N; Ehrlich E; Dana MR; Benichou G
    J Immunol; 2001 Aug; 167(4):1891-9. PubMed ID: 11489968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect T cell recognition in allograft rejection.
    Bradley JA
    Int Rev Immunol; 1996; 13(3):245-55. PubMed ID: 8782745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
    Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
    J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways of allorecognition: implications for transplantation tolerance.
    Game DS; Lechler RI
    Transpl Immunol; 2002 Aug; 10(2-3):101-8. PubMed ID: 12216939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-dressed dendritic cells sustain effector T cell responses in islet and kidney allografts.
    Hughes AD; Zhao D; Dai H; Abou-Daya KI; Tieu R; Rammal R; Williams AL; Landsittel DP; Shlomchik WD; Morelli AE; Oberbarnscheidt MH; Lakkis FG
    J Clin Invest; 2020 Jan; 130(1):287-294. PubMed ID: 31763998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
    Zhang QW; Kish DD; Fairchild RL
    J Immunol; 2003 Jun; 170(11):5530-7. PubMed ID: 12759430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin-conditioned, alloantigen-pulsed myeloid dendritic cells present donor MHC class I/peptide via the semi-direct pathway and inhibit survival of antigen-specific CD8(+) T cells in vitro and in vivo.
    Fischer RT; Turnquist HR; Wang Z; Beer-Stolz D; Thomson AW
    Transpl Immunol; 2011 Jul; 25(1):20-6. PubMed ID: 21596137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens.
    Coudert JD; Coureau C; Guéry JC
    J Immunol; 2002 Sep; 169(6):2979-87. PubMed ID: 12218112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of the CD4 T Cell Alloresponse: The Short and the Long of It.
    Ali JM; Negus MC; Conlon TM; Harper IG; Qureshi MS; Motallebzadeh R; Willis R; Saeb-Parsy K; Bolton EM; Bradley JA; Pettigrew GJ
    Cell Rep; 2016 Feb; 14(5):1232-1245. PubMed ID: 26804905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cell recognition of a single discordant HLA-A2-transgenic molecule through the indirect antigen presentation pathway induces acute rejection of murine cardiac allografts.
    Smith CR; Jaramillo A; Liu W; Tu Y; Kaleem Z; Swanson CJ; Mohanakumar T
    Transplantation; 2001 Jun; 71(11):1640-8. PubMed ID: 11435977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
    Clement JD; Chan SY; Bishop DK
    Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.